MedTrace Logo

The Effectiveness of a Novel Software Program to Help in ROTEM Interpretation

NCT05591014 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2026-04-27

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess a novel rotational thromboelastometry (ROTEM®) interpretation software to determine whether its use improves the accuracy of clinician interpretation.

Conditions

  • Coagulation Disorder, Blood

Interventions

DEVICE

Novel ROTEM interpretation software

Clinicians will be asked to interpret ROTEM studies before and after exposure to a novel ROTEM interpretation software.

Sponsors & Collaborators

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-13
Primary Completion
2024-12-31
Completion
2024-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05591014 on ClinicalTrials.gov